Normal view MARC view ISBD view

Medicare's ESRD program, Part 2: Transplantation. [electronic resource]

By:

Long, H W

Contributor(s):

Lauve, R M

Producer: 19890718Description: 31-3 p. digitalISSN:

0898-2759

Subject(s):

In: Physician executive vol. 15

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Challenges facing microRNA therapeutics for cystic fibrosis lung disease.
by De Santi, Chiara
2 Growth Stimulatory Effects and Genome-Wide Transcriptional Changes Produced by Protein Hydrolysates in Maize Seedlings.
by Santi, Chiara
3 Nanomodulation of Macrophages in Multiple Sclerosis.
by Nally, Frances K
4 Promotion of arsenic phytoextraction efficiency in the fern Pteris vittata by the inoculation of As-resistant bacteria: a soil bioremediation perspective.
by Lampis, Silvia
5 Non-coding RNA in cystic fibrosis.
by Glasgow, Arlene M A
6 Identification of a novel functional miR-143-5p recognition element in the Cystic Fibrosis Transmembrane Conductance Regulator 3'UTR.
by De Santi, Chiara
7 CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
by Fernandez Fernandez, Elena
8 Genome-Wide Transcriptional Changes and Lipid Profile Modifications Induced by Medicago truncatula N5 Overexpression at an Early Stage of the Symbiotic Interaction with Sinorhizobium meliloti.
by Santi, Chiara
9 Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB.
by Hassan, Tidi
10 Expression of X-linked Toll-like receptor 4 signaling genes in female vs. male neonates.
by O'Driscoll, David N
11 Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.
by De Santi, Chiara
12 Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.
by Fernández Fernández, Elena
13 A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.
by Garritano, Sonia
14 Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
by Pellé, Lucia
15 Expression status of candidate genes in mesothelioma tissues and cell lines.
by Melaiu, Ombretta
16 Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.
by Melaiu, Ombretta
17 Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
by De Santi, Chiara
18 Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.
by De Santi, Chiara
19 Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.
by Cipollini, Monica
20 Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.
by Cipollini, Monica